Amyotrophic lateral sclerosis associated with a pathological expansion in the


Journal

Amyotrophic lateral sclerosis & frontotemporal degeneration
ISSN: 2167-9223
Titre abrégé: Amyotroph Lateral Scler Frontotemporal Degener
Pays: England
ID NLM: 101587185

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 7 12 2021
medline: 20 7 2022
entrez: 6 12 2021
Statut: ppublish

Résumé

Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant hereditary neurodegenerative disease caused by the expansion of a CAG-repeat in the ataxin-7 (

Identifiants

pubmed: 34870541
doi: 10.1080/21678421.2021.1998537
doi:

Substances chimiques

Ataxin-7 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

470-472

Auteurs

Florent Cluse (F)

ALS Resource and Competence Centre, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
Electroneuromyography and Neuromuscular Diseases Unit, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.

Emilien Bernard (E)

ALS Resource and Competence Centre, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
Electroneuromyography and Neuromuscular Diseases Unit, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
NeuroMyoGène Institute, CNRS UMR5310, INSERM U1217, University of Lyon I, Lyon, France.

Isabelle Strubi-Vuillaume (I)

Biology and Pathology Centre, University Hospital of Lille, Lille, France.

David Devos (D)

Department of Pharmacology, LiCEND, ALS Expert Center, University Hospital of Lille, University of Lille, Lille Neuroscience & Cognition, Inserm U1172, Lille, France.

Kevin Mouzat (K)

Laboratory of Biochemistry and Molecular Biology, University Hospital of Nîmes, Nîmes, Motoneuron Disease: Pathophysiology and Therapy, INM, University of Montpellier, Montpellier, France.

Serge Lumbroso (S)

Laboratory of Biochemistry and Molecular Biology, University Hospital of Nîmes, Nîmes, Motoneuron Disease: Pathophysiology and Therapy, INM, University of Montpellier, Montpellier, France.

Caroline Froment Tilikete (C)

Neuro-ophtalmology and Neuro-cognition Unit, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
Faculté de médecine Lyon Est, University of Lyon, Lyon, France.
Lyon Neuroscience Research Center, INSERM U1028 CNRS UMR 5292, Team impact, Bron, France.

StÉphane Thobois (S)

ALS Resource and Competence Centre, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
Faculté de médecine et de Maïeutique Lyon Sud Charles Mérieux, University of Lyon, Lyon, France, and.
CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron, France.

Antoine Pegat (A)

ALS Resource and Competence Centre, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.
Electroneuromyography and Neuromuscular Diseases Unit, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH